Torren Management’s CareDx CDNA Stock Holding History

Torren Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.3K	Hold	158	–	–	0.01%	218
2026 Q2	$4.5K	Hold	158	–	–	﹤0.01%	366
2026 Q1	$2.74K	Sell	158 -93	-37%	-$1.76K	﹤0.01%	466
2025 Q4	$4.73K	Buy	+251	New	+$4.2K	﹤0.01%	911

Other funds holding CDNA

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Zweig-DiMenna Associates New York $1.3B AUM 120.13% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Gagnon Advisors New York $182M AUM 52.04% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return

Torren Management's CDNA Position: Q3 2026 in Review

Torren Management held its CareDx (CDNA) position steady in Q3 2026 at 158 shares worth $10.3K. The position accounts for 0.01% of the portfolio, ranked #218.

Torren Management first reported a position in CDNA in Q4 2025 and has held it in 4 quarters since. 109 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

Torren Management held 158 shares of CareDx worth $10.3K as of Q3 2026.
Torren Management left its CareDx share count unchanged in Q3 2026.
CareDx made up 0.01% of Torren Management's portfolio in Q3 2026, its #218 holding.
Torren Management first reported a position in CareDx in Q4 2025 and has held it in 4 quarters since.
109 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Torren Management's 13F filing for Q3 2026, filed 29 Oct 2026.